Premier

Matt Blois looks at how reshoring U.S. drug manufacturing can help solve drug shortages on this episode of Medically Necessary.

Matt Blois looks at what supply chains will look like once the pandemic eventually ends.

Health care utilization had mostly recovered to normal levels by June. As COVID-19 cases rise, it’s hard for health care companies to predict demand for elective procedures, PPE and COVID-19 testing for the rest of 2021.

E-commerce tools have made retail shopping extremely convenient. Now, companies want to bring that convenience to the health care supply chain. Health care’s complex and highly regulated environment may make that difficult.

The story behind shortages of two skin disinfectant products is a parable about the challenges facing medical supply chains right now.

As the number of COVID-19 cases decreases, some manufacturers and suppliers of personal protective equipment are predicting demand will start to drop over the coming months.